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Low grade squamous intra-epithelial lesions could be considered as a manifestation of human papillomavirus exposition,
however the discrepancy between rates of infection with human papillomavirus and development of low grade squamous
intra-epithelial lesions is notable. Here we report a cross-sectional three-armed case–control study in the Colombian
population, to compare the risk factors of women with low grade squamous intra-epithelial lesions with that of human
papillomavirus DNA-negative and positive women with normal cytology.
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Cervical cancer, the main cause of death from cancer among
Colombian women, is known to be preceded by a series of squa-
mous intra-epithelial lesions (SIL). Recently it has been
established that human papillomavirus (HPV) is not only the
central cause of cervical cancer, but also a necessary cause
(Walboomers et al, 1999).
Natural history studies indicate that the chain of events leading
to cervical cancer starts with HPV infection, followed by high-
grade squamous intra-epithelial lesions (HSIL) and cancer. The
category HPV infection could include a range of diagnoses from
HPV DNA detectable only by PCR without cytological abnormal-
ities (latent HPV infection) to CIN-1 lesions indistinguishable
from koilocytic atypia, called low-grade squamous intra-epithelial
lesions (LSIL) or productive HPV infection. LSIL should then be
considered as a sign of exposure to HPV.
It is currently unclear if the determinants of HPV DNA detec-
tion in women with normal cytology are the same or similar to
those of LSIL. A recent follow-up study in young women suggests
that risk factors for HPV infection are different from those of LSIL
(Moscicki et al, 2001).
In a previous study the risk factors for HPV DNA detection
among Colombian women with normal cytology were identiﬁed
(Molano et al, 2002). We report here a cross-sectional three-armed
case-control study in the same population, to compare the risk
proﬁle of women with LSIL lesions with that of HPV DNA-nega-
tive and positive women with normal cytology.
MATERIALS AND METHODS
Study population
This study was conducted in Bogota, Colombia. Brieﬂy, between
1993 and 1995 the Colombian Cancer Institute conducted a census
in four health districts in Bogota. The ﬁrst 2000 women aged 18–
85 years identiﬁed in the census were invited to participate. In
addition, 200 adolescents aged 13–17 years consulting an adoles-
cent clinic giving contraceptive counselling were also invited to
participate. At recruitment, all women were interviewed by
specially trained interviewers using a structured questionnaire on
socio-demographic characteristics, lifelong sexual behaviour, repro-
ductive history, smoking and dietary habits. After interview all
women underwent a pelvic examination during which cervical
scrapes were collected for routine Pap smear and HPV DNA and
Chlamydia trachomatis detection.
Out of the 2200 invited women, 53 refused to participate, eight
were considered ineligible (history of hysterectomy or cervical
cancer, mental illness), 14 did not ﬁll in the epidemiological ques-
tionnaire, 29 did not provide cervical scrapes and 1010 had
inadequate cervical specimens for ampliﬁcation, as measured by
failure to amplify a human b-globin fragment. Thus 1995
(90.7%) women with a cytological diagnosis and with adequate
cervical samples for HPV DNA and C. trachomatis PCR testing
constitute the sampling frame for the study. Informed consent
was obtained from all women and the ethical committees of the
National Cancer Institute of Colombia and of the IARC cleared
the study protocol.
Case-control selection
The smears taken at recruitment were read by two expert cyto-
pathologists as follows: normal cytology in 1845 women (92.5%),
LSIL in 70 (3.5%) women, atypical squamous cells of undeter-
mined signiﬁcance (ASCUS) in 30 (1.5%), atypical glandular cells
of undetermined signiﬁcance (AGUS) in 14 (0.7%), HSIL in 8
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inadequate Pap smears.
Cases for the case–control analysis were those with a diagnosis
of LSIL (two cases diagnosed HSIL at cytology, but classiﬁed LSIL
at histology are included. On the other hand, two cases ﬁrst classi-
ﬁed as LSIL at cytology were diagnosed HSIL and cancer in situ at
histology and were excluded). Controls were selected from the pool
of 1845 women with normal cytology. Eight controls per case with
LSIL diagnosis were selected, matched for age (+2 years) and date
of recruitment (+6 months), giving a total of 557 control women.
Two subgroups of control women were compared to the cases: one
of 459 HPV DNA-negative and another of 98 HPV DNA-positive
women.
HPV DNA detection and genotyping
HPV DNA detection in the samples was performed previously by a
standard GP5+/GP6+ PCR EIA-based assay (de Roda Husman et
al, 1995). Brieﬂy, HPV-positive samples were subjected to EIA
HPV group-speciﬁc analysis using cocktail probes for high- and
low-risk HPVs (Jacobs et al, 1997). The high-risk HPV cocktail
probe consisted of oligoprobes for HPV 16, 18, 31, 33, 35, 39,
45, 51, 52, 56, 58, 59, 66 and 68 and the low-risk HPV consisted
of oligoprobes for HPV 6, 11, 40, 42, 43, 44, HPV 82 (MM4),
(Iso 39) HPV 83 (MM7), HPV 84 (MM8), HPV 71 (CP8061),
HPV 81 (CP8304), HPV 26, 34, 53, 54, 55, 57, 61, 70, 72 and
73. Additionally, HPV positivity was assessed by Southern blot
hybridisation of GP5+/GP6+ PCR products with the general probe
of speciﬁc [a-
32P]dCTP-labelled fragments from cloned DNA of
HPV 6, 11, 16, 18, 31, and 33 (van den Brule et al, 1990; de Roda
Husman, 1995). Samples which were positive by Southern blot
analyses and negative by high-risk/low-risk EIA were considered
as HPV X or undetermined type.
Chlamydia trachomatis detection by PCR
The detection of C. trachomatis was performed as described
previously (Morre ￿ et al, 1998). Plasmid endogenous-speciﬁc bioti-
nylated primers were used for PCR ampliﬁcation. The biotinylated
PL6.1/PL6.2 PCR products were detected using an enzyme immu-
noassay as described previously (Jacobs et al, 1997; Munk et al,
1999). As a positive control, a 10-fold dilution series of C. tracho-
matis L2 DNA was used as previously described (Morre ￿ et al,
1996), resulting in a detection sensitivity corresponding to 0.01–
0.1 inclusion forming units (IFU).
Statistical analysis
Odds ratios (ORs) and 95% conﬁdence intervals (CIs) were esti-
mated using unconditional logistic regression. Two separate
analyses were performed. The ﬁrst, analysing risk factors for the
development of LSIL, compared LSIL (all) to a matched sample
of cytology controls. The second compared LSIL-positive for
HPV DNA with two subgroups of normal cytology controls, one
including only HPV DNA-negative controls, the other including
only HPV DNA-positive controls.
The ORs estimates were adjusted for age (grouped as 520, 20–
24, 25–29, 30–34, 35–39, 40–44, 45–54, 555).
RESULTS
The estimated overall HPV DNA prevalence in the total study
population from which we selected our three study groups was
16.5%. Table 1 presents the distribution of study subjects, the
prevalence of HPV DNA by diagnostic category and the age-
adjusted ORs for any type of HPV. More severe lesions were asso-
ciated with higher prevalence of HPV DNA, higher prevalence of
high-risk HPV types and higher ORs. No association with HPV
was observed for the group diagnosed as ASCUS/AGUS.
Table 2 shows the distribution of the HPV types detected in 70
women diagnosed with LSIL and in 557 control women. Eighteen
different types were detected in LSIL and 30 among controls. HPV
6, 73 and CP6108 were exclusively found in LSIL and HPV types
11, 34, 40, 43, 44, 53, 54, 59, 68, 72, MM&, ISO39 and MM8 were
exclusively detected among controls. The most common type
detected in both cases and controls was HPV 16. All women with
multiple infections (except one) had at least one high-risk type and
the prevalence of these multiple infections among HPV-positive
women was similar in LSIL (30.8%) and controls (27.6%).
The age-adjusted OR for LSIL associated with single HPV infec-
tions was 6.1 (95% CI=3.4–10.9) while that for multiple infections
was 7.6 (95% CI=3.4–16.9). The median age of women with LSIL
was 30.8. The prevalence of this diagnosis was higher in women
younger than 25 years where it was 4.4% and then decreased to
1.7% in women over 55–64 years old and 0.0 in women over
65. The prevalence of C. trachomatis was 7.1% in the overall LSIL
group and 5.2% in the control group (Table 3).
When all LSIL cases (HPV-positive and HPV-negative) were
compared with all controls (HPV-positive and negative) and ORs
adjusted for age and HPV were estimated, a signiﬁcantly reduced
risk appeared with ever use of OCs. Non-signiﬁcant increased risk
associated with the detection of C. trachomatis and non-signiﬁcant
decreased risks with number of partners, age at ﬁrst sexual inter-
course and smoking were observed (Table 3). When women with
HPV DNA-positive LSIL were compared with HPV DNA-negative
controls (Table 3), a signiﬁcant increased risk for women attaining
higher educational level was observed, and the reduced risk with
number of partners, age at ﬁrst sexual intercourse and with ever
use of OCs persisted, however non-signiﬁcantly. When HPV
DNA-positive LSIL was compared with HPV DNA-positive
controls, the reduced risk associated with the use of OCs was
signiﬁcant (OR=0.3; 95% CI=0.1-0.7), while the association with
higher education lost statistical signiﬁcance, and non-signiﬁcant
decreased risks with age at ﬁrst sexual intercourse, number of part-
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Table 1 Diagnosis, HPV and age-adjusted odds ratios
Detection of HPV DNA
Age-adjusted
Prevalence of High-risk Low-risk Uncharac Single Multiple Any HPV OR for any HP
Diagnosis Number diagnosis HPV % HPV % HPV % infections % infections % types % (95% Cl)
Normal-total 1845 92.5% 11.4 3.2 0.4 10.5 4.4 14.9 1
ASCUS/AGUS 44 2.2% 4.6 4.6 0.0 6.8 2.3 9.1 0.7 (0.3–2.1)
LSIL 70 3.5% 47.1 4.3 4.3 38.6 17.1 55.7 7.4 (4.5–12.3)
HSIL/Cancer 10 0.5% 70.0 10.0 0.0 70.0 10.0 80.0 31.2 (6.4–150.7)
Inadequate smear 26 1.3% 7.7 3.9 0.0 7.7 3.9 11.5 1.2 (0.4–4.4)
Total Diagnosis 1995 100.0% 12.7 3.3 0.5 11.7 4.8 16.5
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observed.
DISCUSSION
We report here the prevalence of cervical neoplasia and of HPV
types in a Colombian high-risk population.
The estimated overall prevalence of HPV was 16.5%. Among
women with normal cytology it was 14.9%, while in LSIL it was
55.7%. Under the premise that HPV is a necessary cause of cervical
cancer, we should expect that all true pre-neoplastic lesions contain
HPV DNA. Thus, the 44.3% of HPV-negative LSIL could represent
errors of diagnosis (false LSIL diagnosis), low sensitivity of the
HPV assay or both. Considering that the PCR-based assays used
in this study have shown excellent performance in previous inves-
tigations, the possibility of a misdiagnosis of LSIL is more likely. In
line with this possibility is the fact that the prevalence of LSIL in
this Colombian population (3.5%) was higher than the one
reported in another high-risk population in Costa Rica (2.2%)
using more strict diagnostic criteria (Herrero et al, 2000). The
HPV DNA prevalence among women with normal cytology
(14.9%) is similar to that reported from other high-risk popula-
tions in Mexico (14.5%) (Lazcano et al, 2001) and in previous
studies carried out in Cali, Colombia (13%) (Mun ˜oz et al, 1996a).
To assess the determinants of LSIL we carried out a three-armed
case–control analysis in which all LSIL cases (HPV-positive or
HPV-negative) were compared with a control group of normal
cytology, independently of HPV status. Then LSIL HPV-positive
cases were compared with two control groups: one composed by
HPV-negative women with normal cytology and a second one of
HPV-positive women with normal cytology.
Surprisingly, no association with the number of sexual partners
was observed when LSIL cases were compared with HPV negative
controls and a reduced risk of LSIL was associated with oral
contraceptive (OC) use. These ﬁndings are in contrast to the risk
factors for HPV DNA detection identiﬁed in women with normal
cytology from the same study population. Molano et al (2002)
have previously reported that both number of sexual partners
and OC use were associated with an increased risk of HPV
DNA detection in Colombian women with normal cytology. Our
inconsistent results concerning number of sexual partners might
be explained by the importance and the difﬁculty in assessing
the role of male sexual behaviour in determining the risk of cervi-
cal neoplasia, as evidenced in previous studies in Colombia
(Mun ˜oz et al, 1996b).
In relation to OC use, our results are in line with those reported
by Schiffman et al (1993) in a US population, that found a non-
signiﬁcantly reduced risk of CIN lesions among HPV-positive
women associated with OC use, but not with those of a recent
report by Moscicki et al (2001). They found that OC use had a
protective effect for incident HPV infection, but it was not a risk
factor for incident LSIL.
M
o
l
e
c
u
l
a
r
a
n
d
C
e
l
l
u
l
a
r
P
a
t
h
o
l
o
g
y
Table 2 HPV types distribution in women with LSIL and control women
LSIL cases Controls
Single Multiple Single or Single Multiple Single or
HPV types infection infection multiple infection infection multiple
62 2
11 123
16 4 3 7 23 4 27
1 8 55257
3 1 123167
3 3 336167
34 11
35 1 1 2 3 3
3 9 2131 1
40 112
4 2 11235
43 33
44 11
4 5 33189
5 1 123213
5 2 552 2
53 112
54 22
5 6 1232 3
5 8 22485 1 3
59 123
6 6 11 22
68 22
7 0 221 1
72 11
73 1 1
CP6108 1 1
CP8304 1 1 2 5 1 6
MM7 11
MM8 213
ISO39 11
HR 415
11 4 2 6
L R 33 11
X
High-risk types in bold.
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as a risk factor for LSIL in other populations. For example,
Kru ¨ger-Kjær et al (1998) found a positive association with smoking
for both LSIL and HSIL among HPV-positive women in Denmark.
Moscicki et al (2001) also identiﬁed smoking as a risk factor for
LSIL in a cohort study of young US women.
Although our study was limited, for the small number of cases,
it indicates that with the possible exception of OC, we were unable
to identify any other important co-factor for the development of
LSIL. An additional major limitation of our study, as well as of
the vast majority of the studies of LSIL is the inaccuracy of the
cytological diagnosis of LSIL. We have attempted to circumvent
this limitation by restricting the analysis to HPV-positive-LSIL,
but this considerably limited the power of our study.
On the other hand, studies aimed to assess cofactors for HSIL
and cervical cancer have identiﬁed parity, smoking and long-term
OC use as important cofactors that modulate the risk of progres-
sion from HPV infection or LSIL to HSIL and cervical cancer
(Deacon et al, 2000; Hildesheim et al, 2001; Lacey et al, 2001;
Moreno et al, 2002; Mun ˜oz et al, 2002).
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